nasal spray, FDA and Recall

FDA recalls 90K bottles of nasal spray due to potential ‘adverse’ effects: Throw out ASAP
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
Don’t use this nasal spray: FDA says it may cause ‘adverse’ effects
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the manufacturer, NeilMed Pharmaceuticals Inc., the FDA said.
Over 89,000 Bottles of Nasal Spray Recalled By FDA—What to Know
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays due to concerns related to a “microbial failure.”
Nasal Spray Formulation of Bumetanide Under FDA Review
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects during flu season, throw out ASAP
If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause “adverse” medical effects.
Boing Boing on MSN4mon
New nasal spray blocks 99.99% of flu and Covid viruses
The gel is called Pathogen Capture and Neutralizing ... Experiments in mice showed that a single dose of the PCANS nasal ...
Interesting Engineering on MSN4mon
New nasal spray offers 99.99% protection against flu, pneumonia, COVID-19
“PCANS forms a gel, increasing its mechanical strength ... Further tests in mice revealed that a single dose of PCANS ...
Massachusetts man first in country to try new Alzheimer's nasal spray treatment
Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...
Wicked Local2d
New treatment for Alzheimer's via nasal spray being piloted by Massachusetts man
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
Newsweek23d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
UPI23d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...